Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 6;195(43):E1489-E1491.
doi: 10.1503/cmaj.230317-f.

Syndrome pseudogrippal avec choc induit par la rifampicine chez une patiente atteinte d’infection tuberculeuse

[Article in French]
Affiliations

Syndrome pseudogrippal avec choc induit par la rifampicine chez une patiente atteinte d’infection tuberculeuse

[Article in French]
Gousia Dhhar et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Intérêts concurrents: Aucun déclaré.

References

    1. Martínez E, Collazos J, Mayo J. Hypersensitivity reactions to rifampin. Pathogenetic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactions. Medicine (Baltimore) 1999;78:361–9. - PubMed
    1. Sadanshiv M, George AA, Mishra AK, et al. . Rifampicin-induced immune allergic reaction. Trop Doct 2018;48:156–9. - PubMed
    1. Calaquian LL, De A. Rifampin-associated flu-like syndrome in a patient undergoing treatment for a device-related infection. Cureus 2020;12:e12336. - PMC - PubMed
    1. Grosset J, Leventis S. Adverse effects of rifampin. Rev Infect Dis 1983;5 (Suppl 3):S440–50. - PubMed
    1. Sterling TR, Moro RN, Borisov AS, et al. . Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT Tuberculosis study. Clin Infect Dis 2015;61:527–35. - PMC - PubMed